1 Study Coverage 1.1 Chronic Heart Failure (CHF) Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Anti-clotting (Aspirin) 1.2.3 Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor) 1.2.4 Anticoagulant Medicines (Warfarin) 1.2.5 Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors) 1.2.6 Angiotensin II Receptor Blockers (ARB) 1.2.7 Statins 1.2.8 Diuretics 1.2.9 Nitrates 1.3 Market by Application 1.3.1 Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Chronic Heart Failure (CHF) Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Chronic Heart Failure (CHF) Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Chronic Heart Failure (CHF) Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Chronic Heart Failure (CHF) Drugs Sales by Region 2.4.1 Global Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Chronic Heart Failure (CHF) Drugs by Region (2023-2028) 2.5 Global Chronic Heart Failure (CHF) Drugs Revenue by Region 2.5.1 Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) 2.5.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Chronic Heart Failure (CHF) Drugs Sales by Manufacturers 3.1.1 Global Top Chronic Heart Failure (CHF) Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Chronic Heart Failure (CHF) Drugs in 2021 3.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturers 3.2.1 Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Chronic Heart Failure (CHF) Drugs Revenue in 2021 3.3 Global Chronic Heart Failure (CHF) Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Chronic Heart Failure (CHF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Chronic Heart Failure (CHF) Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Chronic Heart Failure (CHF) Drugs Sales by Type 4.1.1 Global Chronic Heart Failure (CHF) Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) 4.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Type 4.2.1 Global Chronic Heart Failure (CHF) Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Chronic Heart Failure (CHF) Drugs Price by Type 4.3.1 Global Chronic Heart Failure (CHF) Drugs Price by Type (2017-2022) 4.3.2 Global Chronic Heart Failure (CHF) Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Chronic Heart Failure (CHF) Drugs Sales by Application 5.1.1 Global Chronic Heart Failure (CHF) Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) 5.2 Global Chronic Heart Failure (CHF) Drugs Revenue by Application 5.2.1 Global Chronic Heart Failure (CHF) Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Chronic Heart Failure (CHF) Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Chronic Heart Failure (CHF) Drugs Price by Application 5.3.1 Global Chronic Heart Failure (CHF) Drugs Price by Application (2017-2022) 5.3.2 Global Chronic Heart Failure (CHF) Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Chronic Heart Failure (CHF) Drugs Market Size by Type 6.1.1 North America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028) 6.1.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028) 6.2 North America Chronic Heart Failure (CHF) Drugs Market Size by Application 6.2.1 North America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028) 6.2.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028) 6.3 North America Chronic Heart Failure (CHF) Drugs Market Size by Country 6.3.1 North America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028) 6.3.2 North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Chronic Heart Failure (CHF) Drugs Market Size by Type 7.1.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028) 7.1.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028) 7.2 Europe Chronic Heart Failure (CHF) Drugs Market Size by Application 7.2.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028) 7.2.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028) 7.3 Europe Chronic Heart Failure (CHF) Drugs Market Size by Country 7.3.1 Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028) 7.3.2 Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Type 8.1.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Application 8.2.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Chronic Heart Failure (CHF) Drugs Market Size by Region 8.3.1 Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Type 9.1.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028) 9.1.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028) 9.2 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Application 9.2.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028) 9.2.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028) 9.3 Latin America Chronic Heart Failure (CHF) Drugs Market Size by Country 9.3.1 Latin America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028) 9.3.2 Latin America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Type 10.1.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Application 10.2.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Chronic Heart Failure (CHF) Drugs Market Size by Country 10.3.1 Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Overview 11.1.3 Abbott Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Abbott Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Abbott Recent Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Corporation Information 11.2.2 Johnson & Johnson Overview 11.2.3 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Johnson & Johnson Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Johnson & Johnson Recent Developments 11.3 Merck 11.3.1 Merck Corporation Information 11.3.2 Merck Overview 11.3.3 Merck Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Merck Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Merck Recent Developments 11.4 Stanley Pharmaceuticals 11.4.1 Stanley Pharmaceuticals Corporation Information 11.4.2 Stanley Pharmaceuticals Overview 11.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Stanley Pharmaceuticals Recent Developments 11.5 New Haven Pharmaceuticals, Inc. 11.5.1 New Haven Pharmaceuticals, Inc. Corporation Information 11.5.2 New Haven Pharmaceuticals, Inc. Overview 11.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 New Haven Pharmaceuticals, Inc. Recent Developments 11.6 Pfizer 11.6.1 Pfizer Corporation Information 11.6.2 Pfizer Overview 11.6.3 Pfizer Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Pfizer Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Pfizer Recent Developments 11.7 GlaxoSmithKline plc 11.7.1 GlaxoSmithKline plc Corporation Information 11.7.2 GlaxoSmithKline plc Overview 11.7.3 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 GlaxoSmithKline plc Recent Developments 11.8 Novartis International AG 11.8.1 Novartis International AG Corporation Information 11.8.2 Novartis International AG Overview 11.8.3 Novartis International AG Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Novartis International AG Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Novartis International AG Recent Developments 11.9 Biovail Corporation 11.9.1 Biovail Corporation Corporation Information 11.9.2 Biovail Corporation Overview 11.9.3 Biovail Corporation Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Biovail Corporation Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Biovail Corporation Recent Developments 11.10 Bristol-Myers Squibb Company 11.10.1 Bristol-Myers Squibb Company Corporation Information 11.10.2 Bristol-Myers Squibb Company Overview 11.10.3 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Bristol-Myers Squibb Company Recent Developments 11.11 Symplmed Pharmaceuticals 11.11.1 Symplmed Pharmaceuticals Corporation Information 11.11.2 Symplmed Pharmaceuticals Overview 11.11.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Symplmed Pharmaceuticals Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Chronic Heart Failure (CHF) Drugs Industry Chain Analysis 12.2 Chronic Heart Failure (CHF) Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Chronic Heart Failure (CHF) Drugs Production Mode & Process 12.4 Chronic Heart Failure (CHF) Drugs Sales and Marketing 12.4.1 Chronic Heart Failure (CHF) Drugs Sales Channels 12.4.2 Chronic Heart Failure (CHF) Drugs Distributors 12.5 Chronic Heart Failure (CHF) Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Chronic Heart Failure (CHF) Drugs Industry Trends 13.2 Chronic Heart Failure (CHF) Drugs Market Drivers 13.3 Chronic Heart Failure (CHF) Drugs Market Challenges 13.4 Chronic Heart Failure (CHF) Drugs Market Restraints 14 Key Findings in The Global Chronic Heart Failure (CHF) Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Anti-clotting (Aspirin) Table 3. Major Manufacturers of Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor) Table 4. Major Manufacturers of Anticoagulant Medicines (Warfarin) Table 5. Major Manufacturers of Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors) Table 6. Major Manufacturers of Angiotensin II Receptor Blockers (ARB) Table 7. Major Manufacturers of Statins Table 8. Major Manufacturers of Diuretics Table 9. Major Manufacturers of Nitrates Table 10. Global Chronic Heart Failure (CHF) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 11. Global Chronic Heart Failure (CHF) Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 12. Global Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) & (Kg) Table 13. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2022) Table 14. Global Chronic Heart Failure (CHF) Drugs Sales by Region (2023-2028) & (Kg) Table 15. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2023-2028) Table 16. Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) & (US$ Million) Table 17. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region (2017-2022) Table 18. Global Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) & (US$ Million) Table 19. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region (2023-2028) Table 20. Global Chronic Heart Failure (CHF) Drugs Sales by Manufacturers (2017-2022) & (Kg) Table 21. Global Chronic Heart Failure (CHF) Drugs Sales Share by Manufacturers (2017-2022) Table 22. Global Chronic Heart Failure (CHF) Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 23. Global Chronic Heart Failure (CHF) Drugs Revenue Share by Manufacturers (2017-2022) Table 24. Chronic Heart Failure (CHF) Drugs Price by Manufacturers (2017-2022) &(USD/g) Table 25. Global Chronic Heart Failure (CHF) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 26. Global Chronic Heart Failure (CHF) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Drugs as of 2021) Table 27. Chronic Heart Failure (CHF) Drugs Manufacturing Base Distribution and Headquarters Table 28. Manufacturers Chronic Heart Failure (CHF) Drugs Product Offered Table 29. Date of Manufacturers Enter into Chronic Heart Failure (CHF) Drugs Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 32. Global Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 33. Global Chronic Heart Failure (CHF) Drugs Sales Share by Type (2017-2022) Table 34. Global Chronic Heart Failure (CHF) Drugs Sales Share by Type (2023-2028) Table 35. Global Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 36. Global Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 37. Global Chronic Heart Failure (CHF) Drugs Revenue Share by Type (2017-2022) Table 38. Global Chronic Heart Failure (CHF) Drugs Revenue Share by Type (2023-2028) Table 39. Chronic Heart Failure (CHF) Drugs Price by Type (2017-2022) & (USD/g) Table 40. Global Chronic Heart Failure (CHF) Drugs Price Forecast by Type (2023-2028) & (USD/g) Table 41. Global Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 42. Global Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 43. Global Chronic Heart Failure (CHF) Drugs Sales Share by Application (2017-2022) Table 44. Global Chronic Heart Failure (CHF) Drugs Sales Share by Application (2023-2028) Table 45. Global Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 46. Global Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 47. Global Chronic Heart Failure (CHF) Drugs Revenue Share by Application (2017-2022) Table 48. Global Chronic Heart Failure (CHF) Drugs Revenue Share by Application (2023-2028) Table 49. Chronic Heart Failure (CHF) Drugs Price by Application (2017-2022) & (USD/g) Table 50. Global Chronic Heart Failure (CHF) Drugs Price Forecast by Application (2023-2028) & (USD/g) Table 51. North America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 52. North America Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 53. North America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 54. North America Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 55. North America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 56. North America Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 57. North America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 58. North America Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 59. North America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg) Table 60. North America Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg) Table 61. North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 62. North America Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 63. Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 64. Europe Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 65. Europe Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 66. Europe Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 67. Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 68. Europe Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 69. Europe Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 70. Europe Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 71. Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg) Table 72. Europe Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg) Table 73. Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 74. Europe Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 75. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 76. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 77. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 78. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 79. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 80. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 81. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 82. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 83. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2017-2022) & (Kg) Table 84. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales by Region (2023-2028) & (Kg) Table 85. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2017-2022) & (US$ Million) Table 86. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue by Region (2023-2028) & (US$ Million) Table 87. Latin America Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 88. Latin America Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 89. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 90. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 91. Latin America Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 92. Latin America Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 93. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 94. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 95. Latin America Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg) Table 96. Latin America Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg) Table 97. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 98. Latin America Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 99. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2017-2022) & (Kg) Table 100. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Type (2023-2028) & (Kg) Table 101. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Type (2017-2022) & (US$ Million) Table 102. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Type (2023-2028) & (US$ Million) Table 103. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2017-2022) & (Kg) Table 104. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Application (2023-2028) & (Kg) Table 105. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Application (2017-2022) & (US$ Million) Table 106. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Application (2023-2028) & (US$ Million) Table 107. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Country (2017-2022) & (Kg) Table 108. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales by Country (2023-2028) & (Kg) Table 109. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Country (2017-2022) & (US$ Million) Table 110. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue by Country (2023-2028) & (US$ Million) Table 111. Abbott Corporation Information Table 112. Abbott Description and Major Businesses Table 113. Abbott Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 114. Abbott Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Abbott Recent Developments Table 116. Johnson & Johnson Corporation Information Table 117. Johnson & Johnson Description and Major Businesses Table 118. Johnson & Johnson Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 119. Johnson & Johnson Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Johnson & Johnson Recent Developments Table 121. Merck Corporation Information Table 122. Merck Description and Major Businesses Table 123. Merck Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 124. Merck Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Merck Recent Developments Table 126. Stanley Pharmaceuticals Corporation Information Table 127. Stanley Pharmaceuticals Description and Major Businesses Table 128. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 129. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Stanley Pharmaceuticals Recent Developments Table 131. New Haven Pharmaceuticals, Inc. Corporation Information Table 132. New Haven Pharmaceuticals, Inc. Description and Major Businesses Table 133. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 134. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 135. New Haven Pharmaceuticals, Inc. Recent Developments Table 136. Pfizer Corporation Information Table 137. Pfizer Description and Major Businesses Table 138. Pfizer Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 139. Pfizer Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Pfizer Recent Developments Table 141. GlaxoSmithKline plc Corporation Information Table 142. GlaxoSmithKline plc Description and Major Businesses Table 143. GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 144. GlaxoSmithKline plc Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 145. GlaxoSmithKline plc Recent Developments Table 146. Novartis International AG Corporation Information Table 147. Novartis International AG Description and Major Businesses Table 148. Novartis International AG Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 149. Novartis International AG Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Novartis International AG Recent Developments Table 151. Biovail Corporation Corporation Information Table 152. Biovail Corporation Description and Major Businesses Table 153. Biovail Corporation Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 154. Biovail Corporation Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Biovail Corporation Recent Developments Table 156. Bristol-Myers Squibb Company Corporation Information Table 157. Bristol-Myers Squibb Company Description and Major Businesses Table 158. Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 159. Bristol-Myers Squibb Company Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Bristol-Myers Squibb Company Recent Developments Table 161. Symplmed Pharmaceuticals Corporation Information Table 162. Symplmed Pharmaceuticals Description and Major Businesses Table 163. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 164. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Symplmed Pharmaceuticals Recent Developments Table 166. Key Raw Materials Lists Table 167. Raw Materials Key Suppliers Lists Table 168. Chronic Heart Failure (CHF) Drugs Distributors List Table 169. Chronic Heart Failure (CHF) Drugs Customers List Table 170. Chronic Heart Failure (CHF) Drugs Market Trends Table 171. Chronic Heart Failure (CHF) Drugs Market Drivers Table 172. Chronic Heart Failure (CHF) Drugs Market Challenges Table 173. Chronic Heart Failure (CHF) Drugs Market Restraints Table 174. Research Programs/Design for This Report Table 175. Key Data Information from Secondary Sources Table 176. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Heart Failure (CHF) Drugs Product Picture Figure 3. Global Chronic Heart Failure (CHF) Drugs Market Share by Type in 2021 & 2028 Figure 3. Anti-clotting (Aspirin) Product Picture Figure 4. Antiplatelet Medicines (Clopidogrel, Prasugrel, and Ticagrelor) Product Picture Figure 5. Anticoagulant Medicines (Warfarin) Product Picture Figure 6. Blood Pressure Maintaining Agents (Angiotensin Converting Enzyme (ACE) Inhibitors) Product Picture Figure 7. Angiotensin II Receptor Blockers (ARB) Product Picture Figure 8. Statins Product Picture Figure 9. Diuretics Product Picture Figure 10. Nitrates Product Picture Figure 11. Global Chronic Heart Failure (CHF) Drugs Market Share by Application in 2021 & 2028 Figure 12. Hospital Figure 13. Clinic Figure 14. Others Figure 15. Chronic Heart Failure (CHF) Drugs Report Years Considered Figure 16. Global Chronic Heart Failure (CHF) Drugs Sales 2017-2028 (Kg) Figure 17. Global Chronic Heart Failure (CHF) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 18. Global Chronic Heart Failure (CHF) Drugs Revenue 2017-2028 (US$ Million) Figure 19. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 20. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2017-2022) Figure 21. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Region (2023-2028) Figure 22. North America Chronic Heart Failure (CHF) Drugs Sales YoY (2017-2028) & (Kg) Figure 23. North America Chronic Heart Failure (CHF) Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 24. Europe Chronic Heart Failure (CHF) Drugs Sales YoY (2017-2028) & (Kg) Figure 25. Europe Chronic Heart Failure (CHF) Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 26. Asia-Pacific Chronic Heart Failure (CHF) Drugs Sales YoY (2017-2028) & (Kg) Figure 27. Asia-Pacific Chronic Heart Failure (CHF) Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 28. Latin America Chronic Heart Failure (CHF) Drugs Sales YoY (2017-2028) & (Kg) Figure 29. Latin America Chronic Heart Failure (CHF) Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 30. Middle East & Africa Chronic Heart Failure (CHF) Drugs Sales YoY (2017-2028) & (Kg) Figure 31. Middle East & Africa Chronic Heart Failure (CHF) Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 32. The Chronic Heart Failure (CHF) Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 33. The Top 5 and 10 Largest Manufacturers of Chronic Heart Failure (CHF) Drugs in the World: Market Share by Chronic Heart Failure (CHF) Drugs Revenue in 2021 Figure 34. Global Chronic Heart Failure (CHF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 35. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 36. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 37. Global Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 38. Global Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 39. North America Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 40. North America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 41. North America Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 42. North America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 43. North America Chronic Heart Failure (CHF) Drugs Sales Share by Country (2017-2028) Figure 44. North America Chronic Heart Failure (CHF) Drugs Revenue Share by Country (2017-2028) Figure 45. U.S. Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 46. Canada Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 47. Europe Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 48. Europe Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 49. Europe Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 50. Europe Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 51. Europe Chronic Heart Failure (CHF) Drugs Sales Share by Country (2017-2028) Figure 52. Europe Chronic Heart Failure (CHF) Drugs Revenue Share by Country (2017-2028) Figure 53. Germany Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 54. France Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 55. U.K. Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 56. Italy Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 57. Russia Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 58. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 59. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 60. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 61. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 62. Asia Pacific Chronic Heart Failure (CHF) Drugs Sales Share by Region (2017-2028) Figure 63. Asia Pacific Chronic Heart Failure (CHF) Drugs Revenue Share by Region (2017-2028) Figure 64. China Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 65. Japan Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 66. South Korea Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 67. India Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Australia Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Taiwan Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Indonesia Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 71. Thailand Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 72. Malaysia Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 73. Philippines Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 74. Latin America Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 75. Latin America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 76. Latin America Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 77. Latin America Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 78. Latin America Chronic Heart Failure (CHF) Drugs Sales Share by Country (2017-2028) Figure 79. Latin America Chronic Heart Failure (CHF) Drugs Revenue Share by Country (2017-2028) Figure 80. Mexico Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 81. Brazil Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 82. Argentina Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 83. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales Market Share by Type (2017-2028) Figure 84. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue Market Share by Type (2017-2028) Figure 85. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales Market Share by Application (2017-2028) Figure 86. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue Market Share by Application (2017-2028) Figure 87. Middle East and Africa Chronic Heart Failure (CHF) Drugs Sales Share by Country (2017-2028) Figure 88. Middle East and Africa Chronic Heart Failure (CHF) Drugs Revenue Share by Country (2017-2028) Figure 89. Turkey Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 90. Saudi Arabia Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 91. UAE Chronic Heart Failure (CHF) Drugs Revenue (2017-2028) & (US$ Million) Figure 92. Chronic Heart Failure (CHF) Drugs Value Chain Figure 93. Chronic Heart Failure (CHF) Drugs Production Process Figure 94. Channels of Distribution Figure 95. Distributors Profiles Figure 96. Bottom-up and Top-down Approaches for This Report Figure 97. Data Triangulation Figure 98. Key Executives Interviewed

Abbott Johnson & Johnson Merck Stanley Pharmaceuticals New Haven Pharmaceuticals, Inc. Pfizer GlaxoSmithKline plc Novartis International AG Biovail Corporation Bristol-Myers Squibb Company Symplmed Pharmaceuticals